In 2004, a painkiller called Vioxx was withdrawn from the market. Why?
Because global Pharmacovigilance teams detected that it increased the risk of heart attacks and strokes.
Protecting Global Health: Why Pharmacovigilance is the Ultimate Corporate Gateway for Life Science Graduates